Speaker

Jatinder Mukker

Senior Director & Head of Quantitative Pharmacology Portfolio, EMD Serono

Jatinder Mukker, Senior Director & Head of Quantitative Pharmacology Portfolio at EMD Serono, is speaking at 2nd Model-Informed Drug Development Summit (Boston, United States of America, 17–19 Nov 2026) in the session “Workshop B: Building Translational & Clinical Evidence Packages That Gets Both Internal & External Stakeholder Buy-In”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Pharmacy & Pharmaceutical Sciences

Upcoming appearances

2nd Model-Informed Drug Development Summit
17–19 Nov 2026Boston, United States of America

More speakers at 2nd Model-Informed Drug Development Summit

Hao Zhu
Division Director, US Food & Drug Administration (FDA)
Souvik Bhattacharya
Associate Director of Pharmacometrics, Astellas Pharma
Bart Borek
Associate Director - Clinical & Quantitative Pharmacology, Vertex Pharmaceuticals
Arunava Chakravartty
Associate Vice President of Biostatistics, Eli Lilly & Co.
Yuan Chen
Senior Fellow, Genentech
Angelica Davenport
Senior Scientist - Clinical Pharmacology & Quantitative Science, Genmab

See all 18 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jatinder Mukker, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].